3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Completed
2
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Conditions
Arthritis, Rheumatoid
2
Cardiovascular Diseases
1
Interventions
Cyclophosphamide
641
Bevacizumab
552
Paclitaxel
534
Carboplatin
533
Cisplatin
480
pembrolizumab
456
Gemcitabine
422
Docetaxel
415
Rituximab
386
Radiotherapy
373
Dexamethasone
351
Doxorubicin
330
Nivolumab
308
Fluorouracil
286
Capecitabine
260
Etoposide
245
Prednisone
244
Oxaliplatin
242
Erlotinib Hydrochloride
242
Cytarabine
233
Lenalidomide
232
Trastuzumab
226
Pemetrexed
220
Vincristine
212
fludarabine phosphate
208
Leucovorin
208
Cetuximab
208
Filgrastim
204
Bortezomib
193
Methotrexate
183
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Has results
×
Antirheumatic Agents
×
Clear all
NCT01548768
2020-11-27
RHYTHM
Columbia University
Phase 4
Completed
149 enrolled
15 charts
NCT02046603
2018-12-07
ACT-MOVE
Hoffmann-La Roche
Phase 3
Completed
162 enrolled
30 charts